NFE2L2 and metastatic malignant neoplasm in the lymph nodes: Increased expression of NRF2 has been positively associated with lymph node metastasis and poor differentiation; also, high expression of NRF2 is associated with poor overall survival of patients with non-small cell lung cancer (NSCLC) [84].